Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-21T07:48:27.794Z Has data issue: false hasContentIssue false
  • English
  • Français

Severe Permanent Encephalopathy in Acute Lymphoblastic Leukemia

Published online by Cambridge University Press:  18 September 2015

L. Maria Bernard ,
Dennis Maureen  and
Obonsawin Marc
L. Maria Bernard*
Affiliation:
Pediatric Neuro-Oncology Program (B.L.M.), Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida; the Department of Psychology (M.D., M.O.), The Hospital For Sick Children, University of Toronto
Dennis Maureen*
Affiliation:
Pediatric Neuro-Oncology Program (B.L.M.), Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida; the Department of Psychology (M.D., M.O.), The Hospital For Sick Children, University of Toronto
Obonsawin Marc*
Affiliation:
Pediatric Neuro-Oncology Program (B.L.M.), Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida; the Department of Psychology (M.D., M.O.), The Hospital For Sick Children, University of Toronto
*
University of Florida College of Medicine, Chief, Division of Pediatric Neurology, Box J-296, J.H.M. Health Center, Gainesville, Florida, USA 32610
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

As survival rates for childhood acute lymphoblastic leukemia have increased, concerns over improved quality-of-life have also increased. Although 3-10% of children may experience acute transient neurotoxicity during induction chemotherapy, they are felt to be at low risk for late sequelae. We report three previously healthy boys with newly-diagnosed acute lymphoblastic leukemia who presented with obtundation and severe seizures during late induction with a standard four drug chemotherapy regimen. While all three are disease-free survivors, they unexpectedly have persistent and medically intractable partial complex seizures, broad-based neuropsychological impairment and striking neuroimaging abnormalities. These findings suggest that children with leukemia who develop an acute encephalopathy during induction chemotherapy are at risk for long-term neurological and neuropsychological sequelae, despite the cessation of further potentially neurotoxic therapy.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 20 , Issue 3 , August 1993 , pp. 199 - 205
Copyright
Copyright © Canadian Neurological Sciences Federation 1993

References

REFERENCES

1.Aur, RJ, Hustu, HO, Verzosa, MS, et al.Comparison of two methods of preventing central nervous system leukemia. Blood 1973; 42: 349–357.CrossRefGoogle ScholarPubMed
2.George, SL, Ochs, J, Mauer, AM, et al.Importance of isolated CNS relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1985; 3: 776–781.CrossRefGoogle ScholarPubMed
3.Ortega, JA, Nesbit, ME, Sather, HN, et al.Long-term evaluation of CNS prophylaxis trial - treatment comparison and outcome after CNS relapse in ALL: a report from the Children's Cancer Study Group. J Clin Oncol 1987; 5: 1646–1654.CrossRefGoogle Scholar
4.Duffner, PK, Cohen, ME. Long-term consequences of CNS treatment for childhood cancer, Part I: pathologic consequences and potential for oncogenesis. Pediatr Neurol 1991; 7: 157–163.CrossRefGoogle Scholar
5.DiMario, FJ Jr, Packer, RJ. Acute mental status changes in children with systemic cancer. Pediatrics 1990; 85: 353–360.CrossRefGoogle ScholarPubMed
6.Ochs, J. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989; 11: 93–105.CrossRefGoogle ScholarPubMed
7.Bleyer, WA, Popleck, DG. Prophylaxis and treatment of leukemia in the central nervous system and other santuaries. Semin in Oncol 1985; 12: 131–148.Google Scholar
8.Ocho, JJ, Parvey, LS, Whitaker, JN, Bowman, WP, et al.Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. J Clin Oncol 1983; 1: 793–798.Google Scholar
9.Duffner, PK, Cohen, ME. Long-term consequences of CNS treatment for childhood cancer, Part II: clinical consequences. Pediatr Neurol 1991; 7: 237–242.CrossRefGoogle ScholarPubMed
10.Pui, CH, Chesney, CM, Weed, J, Jackson, CW. Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia. J Clin Oncol 1985; 3: 1266–1272.CrossRefGoogle ScholarPubMed
11.Packer, RJ, Rorke, LB, Lange, BJ, Seigel, KB, Evans, AE. Cerebrovascular accidents in children with cancer. Pediatrics 1985; 76: 194–201.Google ScholarPubMed
12.Hara, T, Kishikawa, T, Miyazaki, S, Ishii, E, Goya, N. Central nervous system complications in childhood leukemia. Correlation between clinical and computed tomographic finding. Am J Pediatr Hematol Oncol 1984; 6: 129–136.CrossRefGoogle Scholar
13.Kramer, JH, Norman, D, Brant-Zawadzki, M, Ablin, A, Moore, IM. Absence of white matter changes on magnetic resonance imaging in children treated with CNS prophylaxis therapy for leukemia. Cancer 1988; 61: 928–930.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
14.Ebner, F, Ranner, G, Slave, I, et al.MR findings in methotrexate-induced CNS abnormalities. Am J Neuroradiol 1989; 10: 959–964.Google ScholarPubMed
15.Fairclough, D, Ochs, J, Mulhern, R, et al.Comparison of neuropsy-chologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991; 9: 145–151.Google Scholar
16.Lazarus, K, Cairo, MS, Gilmore, RL, et al.Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia. J Pediatr 1980; 97: 829–833.Google Scholar
17.Rivera, GK, Kovnar, E, Pui, CH, et al.Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemia. Hamatol-Bluttransfus 1987; 30: 156–160.Google ScholarPubMed
18.Wechsler, D, Wechsler Intelligence Scale for Children - Revised. NY: The Psychological Corporation, 1974.Google Scholar
19.Spreeno, O and Benton, Al. Neurosensory center comprehensive examination for aphasia: Manual of Directions. Victoria, BC: Neuropsychology laboratory, U. Victoria, 1969.Google Scholar
20.Gaddes, WH and Crockett, DJ. The spreen-Benton aphasia tests, normative data as a measure of normal language development. Brain Lang 1975; 2: 257–280.CrossRefGoogle ScholarPubMed
21.Larrabee, GJ, Curtiss, G. Factor structure and construct validity of the Denman Neuropsychology Memory Scale. Int J Neurosci 1985; 26: 269–276.CrossRefGoogle ScholarPubMed
22.Ryan, EB, Siegel, LS. The development of working memory in normally achieving and subtypes of learning disabled children. Child Dev 1989; 60: 973–980.Google Scholar
23.Webster, RE. Learning Efficiency Test. Novato, CA: Academic Therapy Publications, 1981.Google Scholar
24.Fristoe, M, Goldman, R. Assessment of various auditory perceptual and cognitive skills. J Commun Disord 1975; 8: 171–180.Google Scholar
25.Fletcher, JM. Memory for verbal and nonverbal stimuli in learning disability subgroups: analysis by selective reminding. J Exp Child Psychol 1985; 40: 244–259.CrossRefGoogle ScholarPubMed
26.Johnson, NS, Mandler, JM. Some of the thousand words a picture is worth. J Exp Psychol Hum Learn 1976; 2: 529–540.Google Scholar
27.Saint-Cyr, JA, Taylor, AE, and Lang, AE. Procedural learning and neostriatal dysfunction in man. Brain 1988; 111: 941–959.CrossRefGoogle ScholarPubMed
28.Gordon, M. Errors of omission and commission: a response to Milich and colleagues regarding the Gordon Diagnostic System. Psychopharmacol Bull 1987; 23: 325–328.Google ScholarPubMed
29.Heaton, RK, Pendleton, MG. A comparison of the Wisconsin card sorting test and the category test. J Clin Psychol 1982; 38: 392–396.Google Scholar
30.Chelune, GJ, and Baer, RA. Developmental norms for the Wisconsin card sorting test. J Clin Exp Neuropsychol 1986; 8: 219–228.CrossRefGoogle ScholarPubMed